April 26^th,2023 annual conference Pharmaceuticals – 2023: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss topical issues of industry regulation, changes in the pharmaceutical market in the ongoing era of sanctions and talk about how to protect intellectual property.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2023 the firm is ranked among the TOP leading legal advisors in Russia. 

The new review of the most notable patents disputes in Life Sciences in EAEU.

• pdf, 1.56 Mb

The Russian Constitutional Court in its Ruling of 10 January 2023 No. 1-P  stated that art. 1248(2) of the Russian Civil Code along with art. 106 of the Russian Commercial Procedure Code are inconsistent with the Russian Constitution insofar they prevent a party in a court case on appealing the Rospatent decision to reimburse legal costs borne by this party in administrative dispute on annulling registration of intellectual property objects or means of individualization previously resolved by Rospatent.

On 2 December 2022 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. Lidings’ top position among the leading legal advisors in Russia once again reflected by the ranking results.

In October 2022, the European Commission approved the eighth package of sanctions against Russia. Among other restrictions it established a ban on the provision of legal services to Russian companies. A few weeks later, on October 24, the European Commission published answers to frequently asked questions including explanations as to what kind of legal services fall under the ban and whether the extension of sanctions to this sphere does not entail restrictions on the right to protection.

The Ministry of Industry and Trade approved new amendmends to the Decree on goods admissible for parallel import. That is the 4^th edition of this Decree.

According to the official website of the Eurasian Patent Office (EAPO), the first national patent.

The new Federal law will enter into force on 18 October 2022. The amendments provide for the possibility to challenge extension of a patent related to a medicine, pesticide, or agrochemical (granting SPCs) by filing an opposition with Rospatent according to procedure set out in Article 1398 (2) of the Russian Civil Code if conditions for such patent extension, stipulated in Article 1363 (2) of the Russian Civil Code, have been violated.

Despite the fact that it is possible to obtain a single Eurasian patent by filing an application with the Eurasian Patent Organization (EAPO), the challenge of such patent is proceed separately in each country party of the Eurasian Patent Convention (excluded an administrative annulment of a patent under art. 19(xiii) of the Eurasian Patent Convention and Rule 53 of the Regulations to the Eurasian Patent Convention).